RGT 3.33% 31.0¢ argent biopharma limited

Ann: MGC PHARMA 2021 CLINICAL TRIALS PROGRAM UPDATE, page-4

  1. 1,300 Posts.
    lightbulb Created with Sketch. 580
    https://hotcopper.com.au/data/attachments/3208/3208064-a540215928ae2a6b36abc798dbb5e7b7.jpg
    "Logistical issues surrounding obtaining bulk supply of a key ingredient"


    Well that bodes real well for being able to ramp up production to a meaningful level.

    Not only are they short on manufacturing capability but they can't even source bulk ingredients to even supoort a trial never mind the millions of doses they would like holdersto believethey will be selling.

    Laughable!
    Last edited by StockObserver: 25/05/21
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.010(3.33%)
Mkt cap ! $14.03M
Open High Low Value Volume
31.0¢ 31.0¢ 31.0¢ $921 2.972K

Buyers (Bids)

No. Vol. Price($)
2 7046 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 2380 2
View Market Depth
Last trade - 15.24pm 18/06/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.